Incyte News

Incyte | 8-K: Current report

May 13 07:23 ET

Incyte | 8-K: Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs

Apr 30 07:15 ET

Incyte | DEFA14A: Others

Apr 29 08:28 ET

Incyte | DEF 14A: Definitive information statements

Apr 29 08:27 ET

Incyte | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 13 17:18 ET

Incyte | 8-K: Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities

Feb 13 07:09 ET

Incyte | 8-K: Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

Oct 31, 2023 07:05 ET

Incyte | 8-K: Current report

Sep 12, 2023 17:00 ET

Incyte | 8-K: Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

Aug 1, 2023 07:05 ET

Incyte | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 30, 2023 16:02 ET

Incyte | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 30, 2023 16:02 ET

Incyte | 8-K: Current report

Jun 15, 2023 14:10 ET

Incyte | DEFA14A: Others

Jun 7, 2023 16:47 ET

Incyte | 8-K: Current report

May 8, 2023 17:21 ET

Incyte | 8-K: Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs

May 2, 2023 07:01 ET

Incyte | DEFA14A: Others

Apr 28, 2023 08:03 ET

Incyte | DEF 14A: Definitive proxy statements

Apr 28, 2023 08:00 ET

Incyte | 8-K: Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs

Feb 7, 2023 07:05 ET

Incyte | 8-K: Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

Nov 1, 2022 07:05 ET

Incyte | 8-K: Current report

Oct 4, 2022 07:30 ET